Free Trial
NASDAQ:RDHL

Redhill Biopharma (RDHL) Stock Price, News & Analysis

Redhill Biopharma logo
$2.19 +0.06 (+2.82%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$2.15 -0.04 (-1.78%)
As of 07/11/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Redhill Biopharma Stock (NASDAQ:RDHL)

Key Stats

Today's Range
$2.11
$2.19
50-Day Range
$1.75
$2.19
52-Week Range
$1.71
$20.28
Volume
11,495 shs
Average Volume
164,778 shs
Market Capitalization
$5.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RDHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter.

RDHL Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
RedHill Biopharma Ltd. (RDHL) - Yahoo Finance
See More Headlines

RDHL Stock Analysis - Frequently Asked Questions

Redhill Biopharma's stock was trading at $6.21 at the beginning of the year. Since then, RDHL stock has decreased by 64.7% and is now trading at $2.19.

Redhill Biopharma Ltd. (NASDAQ:RDHL) announced its quarterly earnings data on Tuesday, November, 30th. The biotechnology company reported ($500.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($480.00) by $20.00. The biotechnology company earned $21.61 million during the quarter, compared to the consensus estimate of $23.41 million.

Redhill Biopharma's stock reverse split on the morning of Tuesday, August 20th 2024.The 1-25 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of RDHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Redhill Biopharma investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), Broadcom (AVGO), CymaBay Therapeutics (CBAY) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/30/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RDHL
Previous Symbol
ASX:RDH
CIK
1553846
Employees
210
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.54
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$8.04 million
Price / Sales
0.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.66) per share
Price / Book
-0.60

Miscellaneous

Outstanding Shares
2,300,000
Free Float
2,139,000
Market Cap
$5.04 million
Optionable
No Data
Beta
4.22

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:RDHL) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners